Potent, Selective, and Orally Bioavailable Quinazoline-Based STK17A/B Dual Inhibitors.
Chaudhry S, Castro JR, Totiger TM, Afaghani J, Khurshid R, Nicholls M, Zhang Z, Schürer SC, Shah A, Taylor J, Feng Y.
Chaudhry S, et al. Among authors: taylor j.
ACS Med Chem Lett. 2024 May 20;15(6):945-949. doi: 10.1021/acsmedchemlett.4c00125. eCollection 2024 Jun 13.
ACS Med Chem Lett. 2024.
PMID: 38894933